alagille syndrome - SportsID
Alagille syndrome is a rare multisystem disorder that primarily affects the liver, heart, and kidneys, and is most frequently associated with pathogenic mutations in the JAG1 gene, with a smaller ... Medical Xpress: Novel approach prevents liver damage in animal models of Alagille syndrome Alagille syndrome, a genetic disease estimated to affect 1 in 30,000 individuals, is caused by mutations in the gene JAG1 in most cases. The mutations affect multiple organs including the liver where ...
Understanding the Context
Nasdaq: Event-Free Survival Data from Mirum’s LIVMARLI Alagille Syndrome Program Published in Hepatology Improvement in pruritus, serum bile acid levels and bilirubin were highly predictive of six-year event-free and transplant-free survival in patients with cholestatic pruritus in Alagille syndrome ... Event-Free Survival Data from Mirum’s LIVMARLI Alagille Syndrome Program Published in Hepatology The American Journal of Managed Care: Odevixibat Safe for Alagille Syndrome Based on Hepatic Changes An Ipsen drug developed to treat the severe itching that accompanies certain liver disorders is now FDA approved for treating this complication in patients with Alagille syndrome. It’s the second ... Credit: Getty Images.
Image Gallery
Key Insights
The sNDA is supported by data from the ASSERT study, which included patients less than 17 years old with genetically confirmed Alagille syndrome. The Food and Drug Administration ... A drug to treat severe itching in patients with Alagille syndrome should be granted a marketing authorization in the European Union under what the European Medicines Agency (EMA) termed exceptional ...